tiprankstipranks
Advertisement
Advertisement

MNOV Stock Latest News

Analyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
RatingsAnalyst Reiterates Buy on MediciNova as Advancing Pipeline and Upcoming ALS Catalysts Support Unchanged $6 Price Target
4h ago
MNOV
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
PremiumCompany Announcements
MediciNova Shareholders Reject Proposal to Increase Authorized Stock
7d ago
8K
MNOV
Analyst Initiates Buy on MediciNova, Citing Pivotal Tipelukast and Ibudilast Catalysts to Support $10 Price Target
PremiumRatings
Analyst Initiates Buy on MediciNova, Citing Pivotal Tipelukast and Ibudilast Catalysts to Support $10 Price Target
1M ago
MNOV
Medicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
PremiumRatings
Medicinova: Buy Rating Reiterated as Pipeline Advances and Cash Runway Extends, $6 Price Target Maintained
1M ago
MNOV
MediciNova’s peer-reviewed ibudilast study advances clinical translation
PremiumThe Fly
MediciNova’s peer-reviewed ibudilast study advances clinical translation
2M ago
MNOV
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
PremiumThe FlySuper Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
3M ago
BIP
BOX
Maxim resumes MediciNova at Buy on potential value-driving data events this year
Premium
The Fly
Maxim resumes MediciNova at Buy on potential value-driving data events this year
3M ago
MNOV
MediciNova resumed with a Buy at Maxim
Premium
The Fly
MediciNova resumed with a Buy at Maxim
3M ago
MNOV
MediciNova initiated with a Buy at H.C. Wainwright
PremiumThe Fly
MediciNova initiated with a Buy at H.C. Wainwright
4M ago
MNOV
MediciNova management to meet with Maxim
PremiumThe Fly
MediciNova management to meet with Maxim
4M ago
MNOV
MediciNova issues letter to shareholders
PremiumThe Fly
MediciNova issues letter to shareholders
6M ago
MNOV
MediciNova initiated with a Buy at Lucid Capital
PremiumThe Fly
MediciNova initiated with a Buy at Lucid Capital
6M ago
MNOV
MediciNova Establishes Flexible At-The-Market Equity Program
PremiumCompany AnnouncementsMediciNova Establishes Flexible At-The-Market Equity Program
6M ago
8K
MNOV
MediciNova completes patient enrollment in neuropathy trial of MN-166
Premium
The Fly
MediciNova completes patient enrollment in neuropathy trial of MN-166
7M ago
MNOV
MediciNova files $300M mixed securities shelf
Premium
The Fly
MediciNova files $300M mixed securities shelf
7M ago
MNOV
MediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
PremiumThe Fly
MediciNova names Dr. Christopher Breder as Clinical and Regulatory Advisor
8M ago
MNOV
MediciNova completes patient enrollment in MN-001-NATG-202 trial
PremiumThe Fly
MediciNova completes patient enrollment in MN-001-NATG-202 trial
8M ago
MNOV
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
PremiumThe Fly
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
8M ago
MNOV
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
PremiumThe Fly
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
9M ago
MNOV
MediciNova provides update on SEPA, COMBAT-ALS trial enrollment
PremiumThe FlyMediciNova provides update on SEPA, COMBAT-ALS trial enrollment
10M ago
MNOV
MediciNova achieves enrollment in COMBAT-ALS clinical trial
Premium
The Fly
MediciNova achieves enrollment in COMBAT-ALS clinical trial
10M ago
MNOV
MediciNova files to sell 25M shares of common stock for holders
Premium
The Fly
MediciNova files to sell 25M shares of common stock for holders
10M ago
MNOV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >